COVID-19 studies:
C19 studies:
C19:
Ivermectin
IVM
Vitamin D
V.D
HC
Q
HC
Q
Vitamin C
V.C
Zinc
Zn
BH
BH
FPV
FPV
FLV
FLV
PVP-I
PI
REGN
R2
LY-CoV
LY
RMD
RMD
Ivermectin
IVM
Vitamin D
V.D
HC
Q
HC
Q
Vitamin C
V.C
Zinc
Zn
BH
BH
FPV
FPV
FLV
FLV
PVP-I
PI
REGN
R2
LY-CoV
LY
RMD
RMD
LY-CoV news
10/26 News
Lilly
(News)
Lilly Statement Regarding NIH’s ACTIV-3 Clinical Trial
Source
PDF
Share
Tweet
ACTIV-3 intermin analysis shows LY-CoV555 is unlikely to help hospitalized patients. ACTIV-2, BLAZE-1 and BLAZE-2 trials remain ongoing.
Lilly et al., 10/26/2020, preprint, 1 author.
Details of all 5 studies
Please send us corrections, updates, or comments.
Submit